Trial Profile
Activities of prolonged administration of vinorelbine or capecitabine oral to increase time to progression in patients with stable disease after the first line treatment with vinorelbine + xeloda. Randomized study clinical phase II.
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 29 May 2012
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Vinorelbine (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 29 Jul 2011 New trial record